News/Child Neurology Society (CNS)

Pediatric Neurology Virtual Assistants: EEG Scheduling, Seizure Medication Prior Authorization, Neuropsychological Testing Referrals, and Epilepsy Clinic Coordination

VA Research Team·

Pediatric neurology practices manage some of the most complex and time-sensitive administrative workflows in all of pediatric medicine. A missed EEG authorization can delay epilepsy diagnosis for weeks. A lapsed seizure medication prior authorization can interrupt treatment and increase seizure risk. An uncoordinated neuropsychological testing referral leaves a child with epilepsy or tuberous sclerosis complex (TSC) without the cognitive assessment needed to guide educational planning. Virtual assistants (VAs) trained in pediatric neurology workflows are helping practices and epilepsy centers manage this complexity without increasing clinical staff administrative burden.

EEG Scheduling Coordination

Electroencephalography (EEG) is central to pediatric epilepsy diagnosis and management. Routine outpatient EEGs, ambulatory EEGs, and inpatient video-EEG monitoring studies each require different scheduling pathways, insurance authorization processes, and patient preparation protocols. Ambulatory and video-EEG studies require particularly detailed family preparation — including electrode placement instructions, activity restrictions, and medication hold guidance in some cases — that must be communicated accurately to avoid failed studies.

A VA managing EEG scheduling coordinates prior authorization submission for the appropriate EEG CPT code, confirms neurodiagnostic lab availability, communicates preparation instructions to families in their preferred language, manages confirmation calls, and schedules follow-up visits to review results. The Child Neurology Society emphasizes that timely EEG access is critical for children with new-onset seizures, as early classification of seizure type and epilepsy syndrome guides initial treatment selection. VA-managed scheduling pipelines reduce the time from referral to EEG completion.

Seizure Medication Prior Authorization

Antiseizure medication (ASM) prior authorization is one of the most clinically consequential administrative functions in pediatric neurology. Brand-name ASMs — including Epidiolex (cannabidiol), Fycompa (perampanel), Vimpat (lacosamide), Briviact (brivaracetam), Xcopri (cenobamate), and Fintepla (fenfluramine) — routinely require prior authorization, step-therapy documentation, and, in the case of Fintepla and Epidiolex, enrollment in REMS programs that add additional administrative layers.

A VA supporting seizure medication authorization manages the full cycle: confirming REMS enrollment status where applicable, compiling step-therapy failure documentation, drafting letters of medical necessity, submitting authorizations through insurer portals, tracking approval timelines, and escalating denials to peer-to-peer review requests. For children with drug-resistant epilepsy — who may be on two, three, or four ASMs simultaneously — a VA can manage the entire authorization portfolio, preventing the therapy interruptions that carry serious seizure risk.

Neuropsychological Testing Referral Tracking

Children with epilepsy, TSC, ADHD, and other neurological conditions frequently require neuropsychological evaluation to assess cognitive function, learning profiles, executive function, and adaptive behavior. Neuropsychological testing referrals involve insurance authorization, matching to appropriate neuropsychologists by specialty and age range, managing often-lengthy waitlists (6–18 months at many pediatric centers), preparing families for multi-session evaluations, and coordinating result communication back to the referring neurologist and school.

A VA managing neuropsychological testing referrals tracks each patient's referral status from submission through appointment completion, communicates waitlist position updates to families, confirms insurance authorization status, and coordinates report distribution to the referring neurologist, primary care provider, and school team. This tracking function is particularly important for children with TSC, where neuropsychological findings directly inform educational accommodations and behavioral intervention planning.

Tuberous Sclerosis Complex and Epilepsy Clinic Coordination

Multidisciplinary TSC clinics and comprehensive epilepsy programs require coordinated care across neurology, neuropsychology, nephrology, dermatology, pulmonology, and ophthalmology. Preparing for a multidisciplinary clinic visit involves confirming participation from all relevant specialists, ensuring prior authorization is in place for all planned studies (brain MRI, renal ultrasound, EEG), and communicating the visit structure and preparation requirements to families.

A VA supporting TSC or epilepsy clinic coordination manages the pre-visit workflow: confirming specialist participation, verifying authorization for planned studies, sending preparation communications to families, and coordinating the post-visit summary distribution to the primary care provider and relevant subspecialists. This coordination function is essential for ensuring that multidisciplinary clinic visits deliver their full clinical value.

Reducing Administrative Friction in Pediatric Neurology

Pediatric neurology practices that integrate VAs into EEG scheduling, seizure medication authorization, neuropsychological testing referral, and epilepsy clinic coordination workflows report reduced authorization delays, fewer therapy interruptions, and improved multidisciplinary care coordination. For practices ready to address their administrative backlog, Stealth Agents provides VAs experienced in complex prior authorization workflows and subspecialty scheduling.

Sources

  • Child Neurology Society. "EEG Utilization and Access Guidelines." ChildNeurologySociety.org.
  • Tuberous Sclerosis Alliance. "TSC Multidisciplinary Clinic Standards." TSAlliance.org.
  • Epilepsy Foundation. "Seizure Medication Prior Authorization Advocacy Resources." EpilepsyFoundation.org.
  • FDA. "Epidiolex and Fintepla REMS Program Requirements." FDA.gov.